Clinical trial
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or…
NCT00470405 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00470405 |
|---|---|
| Title | Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma |
| Official title | A Phase I Study of ALIMTA Plus Oxaliplatin Administered Every Other Week in the Treatment of Patients With Metastatic Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Solid Tumor |
| Intervention type | Drug |
| Interventions | oxaliplatin, pemetrexed disodium |
| Enrollment | 25 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 7, 2007 |
| Last update posted | Apr 18, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: